# Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults

> **NCT02355210** · NA · COMPLETED · sponsor: **Rush University Medical Center** · enrollment: 151 (actual)

## Conditions studied

- Intestinal Microbiota and Barrier Function

## Interventions

- **DIETARY_SUPPLEMENT:** Bifidobacteria adolescentis BD1
- **DIETARY_SUPPLEMENT:** Bifidobacteria animalis subsp. lactis BB-12
- **DIETARY_SUPPLEMENT:** Bifidobacteria adolescentis BD1 and galactooligosaccharide
- **DIETARY_SUPPLEMENT:** Bifidobacteria animalis subsp. lactis BB-12 and galactooligosaccharide
- **DIETARY_SUPPLEMENT:** galactooligosaccharide
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02355210
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-10
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2021-11-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02355210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02355210, "Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02355210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*